Foundation Medicine (FMI) Misses Q1 EPS by 6c

Foundation Medicine (NASDAQ: FMI) reported Q1 EPS of ($0.59), $0.06 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $21 million.

Foundation Medicine sees FY2015 revenue of $105-115 million, versus the consensus of $108.7 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• The Gap, Inc. (GAP) Tops Q2 EPS by 3c
• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance